Bone regenerative properties of injectable PGLA-cap composite with TGF-β1 in a rat augmentation model

Journal of Tissue Engineering and Regenerative Medicine

Volumn 1, Issue 6, 2007, Pages 457-464

  Plachokova, Adelina ^a   Link, Dennis ^a   van den Dolder, Juliette ^a   van den Beucken, Jeroen ^a   Jansen, John ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Bone augmentation; Growth factors; Injectable cap cement; PGLA CaP composite; TGF 1

Indexed keywords

BONE; BONE CEMENT; CEMENTS; RATS;

BONE AUGMENTATION; BONE FORMATION; CA-P CEMENTS; GROWTH FACTOR; INJECTABLE CAP CEMENT; INJECTABLES; PGLA-CAP COMPOSITE; PLGA MICROSPHERES; PROPERTY; TGF-Β1;

MICROSPHERES;

CALCIUM PHOSPHATE; LACTIC ACID; LEUKOCYTE ANTIGEN; POLY(METHYL METHACRYLATE); POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ANIMAL MODEL; ARTICLE; BONE; BONE DEVELOPMENT; BONE REGENERATION; CYTOLOGY; DRUG EFFECT; HUMAN; INFLAMMATION; INJECTION; MALE; RAT; TISSUE SCAFFOLD; WISTAR RAT;

ANIMALS; ANTIGENS, CD; BONE AND BONES; BONE REGENERATION; CALCIUM PHOSPHATES; HUMANS; INFLAMMATION; INJECTIONS; LACTIC ACID; MALE; MODELS, ANIMAL; OSTEOGENESIS; POLYGLYCOLIC ACID; POLYMETHYL METHACRYLATE; RATS; RATS, WISTAR; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 45849124262     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.59     Document Type: Article

References (36)

1. Arnaud E, Morieux C, Wybier M, et al. 1994; Potentiation of transforming growth factor-β1 by natural coral and fibrin in a rabbit cranioplasty model. Calcif Tiss Int 54: 493-498.
2. Aspenberg P, Jeppsson C, Wang JS, et al. 1996; Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats. Bone 19: 499-503.
3. Beck LS, Deguzman L, Lee WP, et al. 1991; Rapid publication. TGF-β1 induces bone closure of skull defects. J Bone Miner Res 6: 1257-1265.
4. Beck LS, Amento EP, Xu Y, et al. 1993; TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J Bone Miner Res 8: 753-761.
5. BlomEJ, Klein-Nulend J, Yin L, et al. 2001; Transforming growth factor-β1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects. Clin Oral Implants Res. 12: 609-616.
6. Bosch C, Melsen B, Gibbons R, et al. 1996; Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects. J Craniofac Surg 7: 300-310.
7. Ginebra MP, Fernandez E, Boltong MG, et al. 1994; Compliance of an apatitic calcium phosphate cement with the short-term clinical requirements in bone surgery, orthopaedics and dentistry. Clin Mater 17: 99-104.
8. Glant TT, Jacobs JJ. 1994; Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Orthop Res 12: 720-731.
9. Habraken WJ, Wolke JG, Mikos AG, et al. 2006; Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed 17: 1057-1074.
10. Huse RO, Quinten Ruhe P, Wolke JG, Jansen JA. 2004; The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute. Clin Oral Implants Res 15: 741-749.
11. Janeway CA, Travers P, Walport M, et al. 1999; Immunobiology - The Immune System in Health and Disease, 4th edn. Elsevier Science/Garland: London; 583.
12. Jansen JA, Ruijter JE, Schaeken HG, et al. 1995; Evaluation of tricalciumphosphate/hydroxylapatite cement for tooth replacement: an experimental study. J Mater Sci Mater Med 6: 653-657.
13. Janssens K, ten Dijke P, Janssens S, et al. 2005; Transforming growth factor-β1 to the bone. Endocr Rev 6: 743-774.
14. Khairoun I, Boltong MG, Driessens FC, et al. 1997; Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 38: 356-360.
15. LaTrenta GS,McCarthy JG, Breitbart AS, et al. 1989; The role of rigid skeletal fixation in bone-graft augmentation of the craniofacial skeleton. Plast Reconstr Surg 84: 578-588.
16. Lin KY, Bartlett SP, Yaremchuk MJ, et al. 1990; The effect of rigid fixation on the survival of onlay bone grafts: an experimental study. Plast Reconstr Surg 86: 449-456.
17. Lind M, Frokjaer J, Søballe K, et al. 1994; Inability of local application of transforming growth factor-β to promote healing of defects in rabbit femoral condyles. Eur J Exp Musculoskel Res 3: 131-136.
18. Lind M, Overgaard S, Soballe K, et al. 1996; Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs. J Orthop Res 14: 343-350.
19. Massagué J. 1990; The transforming growth factor-beta family. Annu Rev Cell Biol 6: 597-641.
20. Moxham JP, Kibblewhite DJ, Bruce AG, et al. 1996a; Transforming growth factor-β1 in a guanidine-extracted demineralized bone matrix carrier rapidly closes a rabbit critical calvarial defect. J Otolaryngol 25: 82-87.
21. Moxham JP, Kibblewhite DJ, Dvorak M, et al. 1996b; TGF-β1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. J Otolaryngol 25: 388-392.
22. Okuda K, Nakaijma K, Irie K, et al. 1995; Transforming growth factor-β1-coated β-tricalcium phosphate pellets stimulate healing of experimental bone defects of rat calvariae. Oral Dis 1: 92-97.
23. Ooms EM, Wolke JG, van der Waerden JP, et al. 2003; Use of injectable calcium-phosphate cement for the fixation of titanium implants: an experimental study in goats. J Biomed Mater Res B Appl Biomater 66: 447-456.
24. Phillips JH, Rahn BA. 1990; Fixation effects on membranous and endochondral onlay bone graft revascularization and bone deposition. Plast Reconstr Surg 85: 891-897.
25. Pioletti DP, Takei H, Lin T, et al. 2000; The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials 21: 1103-1114.
26. Plachokova AS, van den Dolder J, Jansen JA. 2008; The bone regenerative properties of Emdogain adsorbed onto PLGA-CaP composites in an ectopic and orthotopic rat model, J Periodontal Res, Published article onlie: 2-Aug-2007 DOI:10.1111/j.1600-0765.2007.00994.x.
27. Puleo DA, Holleran LA, Domerus RH, et al. 1991; Osteoblast response to orthopaedic implants in vitro. J Biomed Mater Res 25: 711-723.
28. Puolakkainen PA, Twardzik D, Ranchalis JE, et al. 1995; The enhancement in wound healing by transforming growth factorbeta 1 (TGF-β1) depends on the topic delivery system. J Surg Res 58: 321-329.
29. Roberts AB, Sporn MB. 1993; Physiological actions and clinical applications of transforming growth factor-beta (TGF-β). Growth Factors 8: 1-9.
30. Ruhe P, Hedberg EL, Padron NT, et al. 2003; rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium phosphate composites. J Bone Jt Surg Am 85-A(suppl 3): 75-81.
31. Ruhe PQ, BoermanOC, Russel FG, et al. 2005; Controlled release of rhBMP-2 loaded poly (DL-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 106: 162-171.
32. Ruhe PQ, Hedberg-Dirk EL, Padron NT, et al. 2006; Porous poly (DLlactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12: 789-800.
33. Shanbhag AS, Macaulay W, Stefanovic-Racic M, et al. 1998; Nitric oxide release by macrophages in response to particulate wear debris. J Biomed Mater Res 5: 497-503.
34. Sumner DR, Turner TM, Purchio AF, et al. 1995; Enhancement of bone ingrowth by transforming growth factor-beta. J Bone and Joint Surg Am 77: 1135-1147.
35. Vuola J, Bohling T, Goransson H, et al. 2002; Transforming growth factor beta released from natural coral implant enhances bone growth at calvarium of mature rat. J Biomed Mater Res 59: 152-159.
36. Zhou H, Choong PC, Chou ST, et al. 1995; Transforming growth factor-β1 stimulates bone formation and resorption in an in vivo model in rabbits. Bone 17(suppl): S 443-448.